A MULTICENTER PROSPECTIVE RANDOMIZED PHASE II STUDY IN PATIENTS WITH CORTICOSTEROID-REFRACTORY/DEPENDENT/INTOLERANT CHRONIC CUTANEOUS GVHD GIVEN EITHER EXTRACORPOREAL PHOTOIMMUNE THERAPY WITH UVADEX IN CONJUNCTION WITH CONVENTIONAL THERAPY OR CONVENTIONAL THERAPY ALONE Greinix, H.T., Van Besien, K., Apperley, J., Bacigalupo, A., Elmaagacli, A., Grigg, A., Kolb, H.-J., Bouzas, L., Michallet, M., Reddy, V.S., Knobler, R.M., Wang, J., Williamson, P., Flowers, M.E.D. Medical University of Vienna, Vienna, Austria; University of Chicago, Chicago; Royal Hammersmith Hospital London, London, United Kingdom; Universitaria San Martino, Genova, Italy; Universitaets-Klinikum Essen, Essen, Germany; Royal Melbourne Hospital, Melbourne, Australia; Ludwig-Maximillians-Universitaet Muenchen, Munich, Germany; INCa, Rio de Janeiro, Brazil; Hopital Edouard Herriot, Lyon, France; University of Florida, Gainesville, FL; Therakos Inc., Exton, PA; Fred Hutchinson Cancer Center and University of Washington, Seattle, WA.